What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for specific lots of Levothyroxine Sodium Tablets, USP. This action involves products manufactured for Accord Healthcare, Inc., a pharmaceutical company based in Raleigh, North Carolina. The affected items are prescription-only strength tablets containing 150 mcg (0.15 mg) of levothyroxine sodium. These medications were packaged in large, 1000-count bottles, which are typically distributed to pharmacies and healthcare facilities rather than directly to individual consumers for home use.
To identify whether you or your pharmacy holds this specific recalled product, you must look closely at the packaging and the bottle labels. The National Drug Code (NDC) for these affected bottles is 16729-455-17. However, the NDC alone is not enough to confirm if a bottle is part of the recall, as multiple lots may share the same NDC. You must verify the specific lot numbers printed on the label. The recall applies exclusively to three distinct lots: D2402195, D2402196, and D2402197. All three of these affected lots share the same expiration date of September 30, 2026.
The manufacturing origin of these tablets is also a key identifier. While Accord Healthcare, Inc. in Raleigh, NC, is listed as the manufacturer for whom the product was made, the physical production took place at Intas Pharmaceuticals Limited. This facility is located in Selaqui, Dehradun, India. The recall encompasses all distribution within the United States, meaning these bottles could have been sent to pharmacies, hospitals, or clinics anywhere in the country. If you are a patient who has recently received a new prescription, it is crucial to check your bottle against the lot numbers listed above. If your medication matches one of the three recalled lots, do not use it. Instead, contact your pharmacy immediately for guidance on obtaining a replacement from a non-recalled lot.
This recall was initiated on August 6, 2026, following the discovery that the drug may be subpotent. Subpotent drugs contain less of the active ingredient than they are supposed to, which can lead to ineffective treatment for the condition being managed. For patients relying on levothyroxine to regulate thyroid hormone levels, even a slight deviation in potency can have significant health implications. Therefore, verifying the lot number is not just a procedural step but a critical safety measure. If you are unsure whether your medication is part of this recall, provide the NDC and lot number to your pharmacist or healthcare provider for verification.
The hazard, explained
At the center of this recall is a specific type of defect known as a "subpotent drug." In plain terms, this means that the medication you are taking contains less of the active ingredient than what is printed on the label. For the Levothyroxine Sodium Tablets affected by this FDA action—specifically those manufactured by Intas Pharmaceuticals Limited and distributed by Accord Healthcare—the 150 mcg (0.15 mg) tablets in question may not be delivering the full dose they promise. This is not a case of the pill being contaminated with a foreign substance or causing an allergic reaction; rather, it is a precision issue. The chemical compound responsible for doing the work inside your body is simply present in a lower quantity than required.
To understand why this matters so much, it helps to look at how Levothyroxine functions within the human body. This medication is a synthetic version of thyroxine (T4), a hormone naturally produced by your thyroid gland. Thyroid hormones act like the master regulators of your metabolism, influencing nearly every organ system in your body. They control your heart rate, body temperature, energy levels, and how quickly you burn calories. Because the body’s sensitivity to these hormones is so acute, even small deviations in dosage can have significant physiological consequences. Unlike some medications where a slightly lower dose might just mean "it works a little slower," thyroid hormone replacement requires strict consistency.
When a drug is subpotent, the mechanism of harm is gradual and cumulative. If you are taking 150 mcg but receiving only, for example, 130 mcg due to manufacturing variations, your body is effectively being treated for hypothyroidism with an insufficient amount of fuel. Over time, this leads to a state of under-medication. The thyroid-stimulating hormone (TSH) levels in your blood may begin to rise again as your body signals that it needs more thyroid hormone. This can cause the return or worsening of symptoms such as profound fatigue, weight gain, cold intolerance, dry skin, hair loss, and difficulty concentrating. In severe cases, particularly for individuals with existing heart conditions, untreated hypothyroidism can lead to elevated cholesterol levels and increased strain on the heart.
The risk is not immediate toxicity, but rather therapeutic failure. For many people, especially those who are elderly or have pre-existing cardiovascular issues, the body cannot compensate for this drop in hormone levels easily. The "harm" here is the loss of stability. You may feel fine one day and increasingly unwell the next as your metabolic rate slows down unexpectedly. This is why the FDA classifies this as a Class II recall: while it is not likely to cause serious adverse health consequences or death in most cases, it does pose a substantial risk of injury due to the critical nature of thyroid hormone regulation. The physical failure lies in the manufacturing process that resulted in tablets with lower-than-stated potency, creating a gap between what you expect to receive and what your body actually gets.
Who is most at risk
When we talk about a recall involving Levothyroxine Sodium, specifically the subpotent tablets distributed by Accord Healthcare, Inc., it is important to understand that the "risk" here is not immediate physical trauma like a broken part or a fire. Instead, the risk is subtle, cumulative, and systemic. This medication is not an over-the-counter pain reliever that you might take occasionally; it is a critical, daily hormone replacement therapy used to treat hypothyroidism, a condition where the thyroid gland does not produce enough hormones. For the thousands of people across the United States who rely on this specific 150 mcg dosage to maintain their metabolic balance, taking a subpotent version means their body is effectively starving for essential fuel.
The primary group at risk consists of adults with diagnosed hypothyroidism who were prescribed this exact strength. Levothyroxine has a very narrow therapeutic index, meaning the difference between a helpful dose and an ineffective one is incredibly small. When the tablets are subpotent, they fail to provide the necessary thyroxine (T4) that the body converts into triiodothyronine (T3), the active hormone regulating heart rate, body temperature, and energy levels. For patients whose conditions are stable on this dosage, introducing a weaker version can lead to a gradual but significant drop in thyroid hormone levels. This is particularly dangerous for individuals who have little to no reserve capacity left in their thyroid function, as they cannot compensate for the lack of medication by producing more naturally.
Within this group, certain populations face heightened vulnerability due to the physiological effects of untreated or undertreated hypothyroidism. Elderly patients are often at greater risk because their bodies may already be experiencing age-related declines in metabolic rate and cardiovascular resilience. A further drop in thyroid hormone levels can exacerbate symptoms such as bradycardia (abnormally slow heart rate), increased cholesterol levels, and fluid retention, which can put additional strain on the heart. For older adults, who may already have underlying cardiac conditions or frailty, these compounded effects can lead to serious complications, including heart failure or worsened cognitive function.
Pregnant individuals are another critical group at risk, although the recall notice does not specify if pregnant patients were targeted. Generally, thyroid hormones are vital for fetal brain development and maternal health during pregnancy. Even a slight reduction in available hormone can have profound implications for both mother and child, potentially affecting neurological development and increasing the risk of miscarriage or preterm birth. While we cannot confirm from the recall facts alone how many pregnant patients received these specific lots, the general medical consensus is that thyroid stability is non-negotiable during gestation.
Finally, anyone with autoimmune thyroid disease, such as Hashimoto’s thyroiditis, is at risk because their immune system is already attacking their thyroid tissue. For them, any external factor that reduces hormone availability—like taking a subpotent pill—can trigger a rapid return of symptoms. These include severe fatigue, depression, weight gain, cold intolerance, and brain fog. While these may seem like minor inconveniences to some, for someone whose life is already managed by strict medical monitoring, the onset of these symptoms can signal a dangerous loss of control over their health status, potentially leading to myxedema coma in extreme, untreated cases. Therefore, the risk is not just about feeling tired; it is about the potential for serious, long-term organ damage and metabolic crisis.
How to tell if you have the recalled item
Because this recall involves a prescription medication rather than a consumer electronic or a toy with a serial number, identifying the affected product requires a careful review of your pharmacy records and the physical packaging itself. The process is straightforward but demands attention to detail, as the risk comes from the specific potency of the drug inside, not just the brand name. Levothyroxine Sodium is a common thyroid medication, and while Accord Healthcare is the brand you will see on the box, many other manufacturers produce similar-looking bottles. Therefore, you cannot rely on the brand name alone to determine if your medication is part of this specific FDA recall.
Your first step should be to locate the original prescription bottle or the outer carton from which it was dispensed. You need to look for two critical pieces of information that must match exactly: the National Drug Code (NDC) and the Lot Number. The NDC acts as a unique identifier for the specific product, manufacturer, and package size. For this recall, the affected item is specifically Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), packaged in 1000-count bottles. The label on these bottles must display the NDC number 16729-455-17. If your bottle has a different NDC, or if it is a different strength (such as 50 mcg or 100 mcg), it is not part of this recall.
Next, you must verify the Lot Number, which identifies the specific batch of tablets manufactured on a particular day. The FDA has identified three specific lot numbers associated with this subpotent drug issue: D2402195, D2402196, and D2402197. These codes are typically printed on the side of the prescription label or clearly visible on the white label affixed to the amber or clear plastic bottle. Additionally, check the expiration date on the package. The recalled lots are scheduled to expire on 09/30/2026. If your bottle bears any of these three lot numbers and matches the NDC and strength described above, you have the recalled item.
If you have lost the original bottle or cannot find the label, do not guess. Contact the pharmacy where you filled the prescription. They maintain digital records that include the NDC and lot number for every medication dispensed to you. Provide them with the date you received the medication and the strength (150 mcg). Ask them specifically if the lot numbers match D2402195, D2402196, or D2402197. This digital verification is often faster and more reliable than trying to decipher faded print on an old bottle. Remember, this distribution was nationwide, so even if you live outside of North Carolina, the medication could still be in your possession.
What to do — step by step
If you currently possess a bottle of Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), manufactured by Accord Healthcare, Inc., the most immediate and critical action you must take is to stop taking the medication right away. Because this specific recall addresses a "subpotent" drug hazard, it means the tablets may not contain the full amount of active ingredient required to effectively treat your condition. Continuing to use these tablets could result in your thyroid hormone levels dropping below what is medically necessary, which can lead to serious health complications. Do not wait for symptoms to appear before acting; prevention is far safer than reaction when dealing with prescription medications.
The next essential step is to contact your healthcare provider or pharmacist immediately. Since the recall details do not explicitly state a return address or a direct consumer hotline from Accord Healthcare, you cannot simply mail the product back on your own. Instead, your doctor needs to know that you have been taking this specific lot so they can monitor your thyroid levels and adjust your treatment plan if necessary. They may prescribe a new supply of Levothyroxine from a different manufacturer or a different lot number to ensure you receive a fully potent dose while you transition away from the recalled product. Your pharmacist is also a vital resource here; they can help verify the National Drug Code (NDC) and lot numbers on your bottle against the recall list and may have information on how to obtain a replacement or refund through their supplier.
You should carefully inspect your medication bottle to confirm it matches the recalled items. Look specifically for the NDC 16729-455-17 and check the expiration date of 09/30/2026. Then, look at the lot number printed on the label. The recall applies only to lots D2402195, D2402196, and D2402197. If your bottle has one of these lot numbers, it is definitely part of this recall. If you have already opened the bottle, do not be alarmed; the risk comes from the chemical potency, not from opening the container. However, keep the bottle intact with its label attached, as the FDA and Accord Healthcare may need this information for their records, even if they do not provide a direct return address in the public notice.
Finally, monitor your body for any changes in how you feel. Subpotent thyroid medication can lead to symptoms such as unusual fatigue, weight gain, sensitivity to cold, or depression. If you experience these symptoms, contact your doctor promptly. While the recall notice does not specify a refund process, your pharmacy may be able to assist with exchanging the product for a non-recalled equivalent or processing a credit to your account. Until you have resolved this with your healthcare team, do not skip doses of any other prescribed medications, and keep all communication records regarding this recall for your personal health files.
Your refund, repair, or replacement options
When you discover that a medication in your cabinet has been recalled, the immediate question is often, "What happens next?" In this specific case involving Accord Healthcare, Inc.’s recall of Levothyroxine Sodium Tablets, 150 mcg, the official FDA recall facts do not explicitly state a standardized remedy such as a direct refund, a repair (which is generally not applicable to pharmaceuticals), or a replacement product. This absence of a stated remedy in the public recall notice is actually quite common for Class II drug recalls, particularly when the issue involves subpotency rather than contamination or physical defects. Instead of a blanket return program, the resolution typically relies on the established relationship between you, your pharmacy, and your healthcare provider.
Because Levothyroxine is a prescription-only medication (Rx Only), you cannot simply walk into a retail store to exchange it like a defective appliance. The "remedy" here is primarily clinical and logistical. Your first step should be to contact the pharmacy where you filled this prescription. They are your primary point of contact for verifying the recall status and arranging for a new, non-recalled prescription if your doctor determines that continuing treatment is necessary. The pharmacy can help ensure that any replacement medication comes from a different lot or manufacturer, providing you with peace of mind that the subpotency issue is completely avoided.
If you have unused bottles of this recalled product, do not attempt to sell them or give them away. The distribution pattern for this recall was nationwide within the United States, meaning these pills are in many homes. Accord Healthcare, Inc., located in Raleigh, NC, and manufactured by Intas Pharmaceuticals Limited in India, has issued this recall due to the subpotent nature of the drug. While the specific instructions for returning the physical product to the manufacturer or distributor are not detailed in the public summary, pharmacies often have protocols for handling recalled drugs. They may ask you to bring the bottles back so they can be properly disposed of in accordance with FDA guidelines. This is crucial because subpotent thyroid medication may not provide the necessary hormone levels your body needs, which can lead to serious health issues if left untreated or improperly managed.
If you are concerned about the cost or access to a replacement, speak with your healthcare provider. They may be able to prescribe a different strength or brand that is currently in stock and unaffected by this recall. In some cases, insurance companies have specific policies for covering alternative medications during a recall, so it is worth asking your insurer about any potential coverage adjustments. Remember, the goal here is not just to get your money back—though you may be able to request a credit or refund from your pharmacy for the unused product—but to ensure your medical treatment continues safely without interruption. Do not stop taking your thyroid medication abruptly; instead, coordinate with your doctor to switch to a verified safe supply as soon as possible.
- Contact Your Pharmacy: Call the pharmacy where you obtained the Levothyroxine Sodium Tablets, USP, 150 mcg. Provide them with the NDC (16729-455-17) and Lot numbers (D2402195, D2402196, or D2402197) to confirm if your specific bottles are part of this recall.
- Consult Your Doctor: Inform your healthcare provider about the recall. They will advise you on whether to switch brands or dosages and can help manage any gaps in your treatment.
- Do Not Self-Remedy: Since no direct return address or refund process is listed for consumers, do not mail the product to Accord Healthcare or Intas Pharmaceuticals unless explicitly instructed by your pharmacy or the FDA. Improper disposal can be hazardous.
What can happen if you ignore it
When a medication is recalled for being subpotent, the danger often lies in its silence. Unlike a broken bottle or a discolored pill that screams for attention, a tablet that contains less of the active ingredient than it claims to look perfectly normal on the outside. This is precisely why ignoring a recall notice regarding Levothyroxine Sodium can be particularly risky. You might take your daily dose with the intention of maintaining your health, but you are actually receiving an incomplete treatment plan without realizing it. Levothyroxine is not like taking a vitamin C supplement or a mild pain reliever where missing a few doses might result in temporary discomfort that resolves on its own. It is a hormone replacement therapy used to treat hypothyroidism, a condition where your thyroid gland does not produce enough of the hormone thyroxine. This hormone is the master regulator of your metabolism, influencing how your body uses energy, how your heart beats, and how your brain functions. When the dosage is consistently lower than prescribed because the drug is subpotent, your body essentially starts to drift back into a hypothyroid state. The immediate consequences might feel subtle at first. You may notice that the fatigue you were managing with this medication begins to creep back in. Your energy levels might drop, making simple tasks like walking up stairs or getting out of bed feel disproportionately difficult. Many people mistake these signs for normal aging, stress, or a busy lifestyle, which is why it is critical to recognize them as potential medical red flags when you are taking thyroid medication. Over time, untreated hypothyroidism can lead to more serious physical changes, such as unexplained weight gain, increased sensitivity to cold, dry skin and hair, and constipation. Beyond the physical toll, there is a significant risk to your cardiovascular and neurological health. Thyroid hormones help regulate heart rate and cholesterol levels. When you are under-medicated, your heart may beat more slowly than it should (bradycardia), and your body’s ability to clear "bad" LDL cholesterol can worsen, potentially increasing long-term strain on your heart. For many individuals, the mental fog associated with hypothyroidism—often described as difficulty concentrating, memory lapses, or depression—can return or intensify, impacting your work performance and personal relationships in ways that are hard to pinpoint without knowing the root cause is a medication discrepancy. It is important to note that while this recall involves Class II hazards, which typically means the situation is serious but not likely to cause permanent health problems if addressed promptly, the cumulative effect of weeks or months of inadequate dosing can still lead to significant clinical issues. For vulnerable populations, such as the elderly, pregnant individuals, or those with pre-existing heart conditions, even a small deviation in thyroid hormone levels can trigger acute medical events. Ignoring the recall does not make the problem disappear; it only allows the gap between your body’s needs and what you are receiving to widen. The goal is to close that gap as quickly as possible by replacing the product, thereby preventing these health declines from becoming chronic or severe.Staying safe: broader tips
When it comes to prescription medications like Levothyroxine, safety is rarely about a single moment of vigilance; it is about building a consistent, reliable routine around how you manage your health. Medications that regulate critical bodily functions, such as thyroid hormone replacement, require precision. Because even minor variations in potency can impact your metabolic rate, energy levels, and overall well-being, treating your medication supply with the same care you would treat any other essential medical device is vital. This means moving beyond passive trust in the supply chain and becoming an active participant in your own safety.
One of the most effective habits you can develop is establishing a direct line of communication with your pharmacist. Your pharmacy team is not just a dispensary; they are your frontline resource for drug safety alerts. When you pick up your prescriptions, take a brief moment to ask if there are any current recalls or safety notices affecting the specific manufacturer or lot number you have been dispensed. While automated systems often flag issues, a quick verbal confirmation ensures you are fully informed. Additionally, consider registering your medications with the FDA’s MedWatch program or signing up for email alerts from reputable health organizations. This proactive approach allows you to receive notifications about potential hazards before they become widespread concerns, giving you time to act calmly and deliberately rather than in reaction to a crisis.
Proper storage is another cornerstone of medication safety that is often overlooked. Environmental factors such as humidity, heat, and light can degrade pharmaceutical compounds over time, potentially altering their effectiveness even if the product has not been officially recalled. Store your Levothyroxine and other sensitive medications in a cool, dry place away from direct sunlight and sources of moisture, such as above the sink or in a medicine cabinet that is frequently opened. Avoid storing them in cars or bathrooms where temperature fluctuations are common. By maintaining stable storage conditions, you help preserve the integrity of the drug within its expiration date, ensuring that what you ingest matches what was intended.
Finally, cultivate a habit of regular review during your annual health check-ups. Share your complete medication list with your healthcare provider and ask them to verify that your current dosage remains appropriate based on recent lab results. This periodic oversight acts as a secondary safety net, catching any discrepancies between your prescribed treatment and your body’s response. By combining vigilant storage practices, proactive communication with healthcare providers, and regular monitoring of official safety alerts, you create a robust defense against potential medication issues, ensuring that your health management remains safe, effective, and stress-free.